Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$30.65 - $35.68 $835,794 - $972,957
-27,269 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$34.33 - $44.68 $2.9 Million - $3.77 Million
-84,337 Reduced 75.57%
27,269 $941,000
Q1 2021

May 14, 2021

SELL
$40.81 - $53.88 $308,972 - $407,925
-7,571 Reduced 6.35%
111,606 $4.81 Million
Q4 2020

Feb 02, 2021

SELL
$36.63 - $47.63 $234,102 - $304,403
-6,391 Reduced 5.09%
119,177 $5.2 Million
Q3 2020

Nov 05, 2020

BUY
$30.09 - $43.02 $87,261 - $124,758
2,900 Added 2.36%
125,568 $4.87 Million
Q2 2020

Aug 12, 2020

BUY
$27.76 - $33.42 $478,332 - $575,860
17,231 Added 16.34%
122,668 $3.97 Million
Q1 2020

May 12, 2020

SELL
$20.69 - $37.79 $105,850 - $193,333
-5,116 Reduced 4.63%
105,437 $3.15 Million
Q4 2019

Jan 27, 2020

BUY
$32.75 - $41.43 $409,375 - $517,875
12,500 Added 12.75%
110,553 $3.8 Million
Q3 2019

Oct 31, 2019

BUY
$33.73 - $46.27 $1.81 Million - $2.49 Million
53,755 Added 121.35%
98,053 $3.31 Million
Q2 2019

Aug 15, 2019

BUY
$29.6 - $40.93 $44,400 - $61,395
1,500 Added 3.5%
44,298 $1.81 Million
Q1 2019

May 03, 2019

SELL
$27.85 - $38.09 $251,095 - $343,419
-9,016 Reduced 17.4%
42,798 $1.33 Million
Q4 2018

Feb 08, 2019

BUY
$32.39 - $42.05 $149,512 - $194,102
4,616 Added 9.78%
51,814 $1.87 Million
Q3 2018

Nov 13, 2018

SELL
$35.69 - $47.65 $81,837 - $109,261
-2,293 Reduced 4.63%
47,198 $1.84 Million
Q2 2018

Aug 15, 2018

BUY
$28.41 - $42.41 $1.41 Million - $2.1 Million
49,491 New
49,491 $1.83 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.23B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.